Neostem lands key patent in Japan


Neostem (NBS +0.9%) says it earned expanded IP protection in Japan for a T-regulatory cell program with a new grant.

The company says the patent will help it grow the reach of its Treg program internationally and accelerate the time to market for cardiovascular disease medicines in Japan.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs